Corporate ActionAug 7, 2026, 04:05 PM
Intellia Therapeutics Awards 38,200 RSUs to New Employees
AI Summary
Intellia Therapeutics, Inc. announced that it awarded inducement grants totaling 38,200 time-based Restricted Stock Units (RSUs) to eight new employees on August 1, 2026. These grants, made under the company's 2024 Inducement Plan, are subject to annual vesting over three years, contingent on the employee's continued service. The awards were approved by the compensation committee as a material inducement for employment, in compliance with Nasdaq Listing Rule 5635(c)(4).
Key Highlights
- Awarded inducement grants to eight new employees on August 1, 2026.
- Grants consisted of 38,200 time-based Restricted Stock Units (RSUs).
- RSUs will vest annually over three years, subject to continued service.
- Awards were made under Intellia’s 2024 Inducement Plan, as amended.
- Approved by the compensation committee as a material inducement for employment.
Price Impact
More from NTLA